Nothing found here
Perhaps You will find something interesting from these lists...
All Blog Posts:
- Nobel Prize 2026: Optogenetics Pioneers Honored for Lighting Up the Brain
- A New Mechanism for Parkinson’s Disease: FDA Approves Tavapadon, the First D1/D5 Dopamine Agonist
- Treating the Cause, Not Just the Symptoms: First Orexin Agonist Approved for Narcolepsy Type 1
- Alzheimer’s Diagnosis Moves to a Simple Blood Draw: New FDA-Cleared Tests in 2026
- Alzheimer’s Treatment at Home: FDA Approves Subcutaneous Lecanemab From the First Dose
- Brain-Computer Interfaces Leave the Lab: Man With ALS Communicates Independently at Home for Two Years
- First Treatment for Alexander Disease: Antisense Therapy Targets the Root Cause
- One Brain, Two Origins: Stanford Study Finds the Brain Develops From Two Separate Cell Populations
- Huntington’s Disease Gene Therapy Reaches FDA Review for the First Time
- Brain-Activated CAR-T Cells Clear a Deadly Childhood Brain Tumor in Preclinical Models
- Breakthrough in Epilepsy Treatment: New Medications Revolutionize Care for Difficult-to-Treat Cases
- World Stroke Day 2024: Act Fast, Save Lives—The Power of Awareness and Early Intervention
- Apple’s Health Innovations: A Game-Changer for Neurological Care?
- Innovative Therapies on the Horizon: Game-Changing Treatments for Neuromuscular Disorders and CIDP
- Vorasidenib Under Fire: Experts Question Efficacy and Ethics of New Brain Tumor Drug
- Revised MS Diagnostic Criteria Unveiled at ECTRIMS 2024: A New Era for Precision in Multiple Sclerosis


